-
Unlocking Access: Overcoming Barriers and Harnessing Enablers for Innovative Payment Models for Pharmaceutical Innovation in Europe
Sep 9, 2025, 16:22 PM -
Prices And Reimbursement Conditions for Poly (ADP-RIBOSE) Polymerase Inhibitors (PARPi) Indicated for Ovarian Cancer in Spain
Sep 9, 2025, 16:22 PM -
The Association of Glucagon-Like Peptide-1 Receptor Agonists With Hepatopancreatobiliary Diseases in Individuals With Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM -
The Estimation of Utility Weights From the Rett Syndrome Behavior Questionnaire
Sep 9, 2025, 16:22 PM -
Publicly Funded Fertility Preservation Services for Medical Reasons in Selected Countries
Sep 9, 2025, 16:22 PM -
Equality Considerations in NICE Guidance of Medical Devices Digital and Diagnostic Technologies and Interventional Procedures
Sep 9, 2025, 16:22 PM -
A Systematic Review (SR) and Network Meta-Analysis (NMA) of Cystic Fibrosis Transmembrane Conductance Receptor (CFTR) Modulator Therapies and Established Clinical Management (ECM) Using Percent Predicted Forced Expiratory Volume in One Second...
Sep 9, 2025, 16:22 PM -
Implementing Coverage With Evidence Development for Medicines With Uncertain Clinical Benefit: Insights From the Netherlands
Sep 9, 2025, 16:22 PM -
Assessing Accuracy of Unsupervised Large Language Model Tools for Identifying Key Criteria Supporting Abstract Screening
Sep 9, 2025, 16:22 PM -
Budget Impact of Metyrapone for the Treatment of Cushing’s Syndrome in France
Sep 9, 2025, 16:22 PM -
Automating PICOs Criteria Assessment in Systematic Reviews With LLMs: Insights From Two Case Studies
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use in Uncontrolled Hypertension: An Observational Study in England Using Electronic Health Records
Sep 9, 2025, 16:22 PM -
Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches
Sep 9, 2025, 16:22 PM -
Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries
Sep 9, 2025, 16:22 PM -
Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM
